Daprof PowerTouch Limited & Daprof Herbal Care and Clinic Internal Memorandum

THE PROBLEM

THE PROBLEM – Having a suitable product in the herbal medicine and clinical online support for consumers. Healing long term illness through herbal medicine.
Netherlands, Figures collected by the European Commission and published by the Integrated Cancer Centre of the Netherlands (IKNL) reveal that people in the Netherlands are more likely to have CANCER than people in almost all other European countries.
Nearly 810,000 Americans are living with KIDNEY FAILURE.
It currently affects more than 1 in 7 — or 15% — of American adults, with people of colour at greater risk for kidney failure.
20 million Nigerian are living with CHRONIC KIDNEY DISEASE and 20000 in END STAGE RENAL FAILURE.
The highest prevalence rate of 7.6% of TYPHOID FEVER in Africa
(Cara Lynn Kim, et al. 2018)
According to Fusheini , Sarfo, and Kofi Gyawu in 2020
Estimates have ranged between 9.9 and 24.2 million cases annually in a district of Ghana over 5 years of retrospective study.
In Ghana, typhoid fever has been ranked among the top twenty causes of outpatient morbidity and constituted 1.2%, 1.7%, and 1.3% of hospital admissions in 2017, 2016, 2015 respectively.

THE SOLUTION

DAPROF HERBAL AND MEDICAL CENTRE has shown evidence for REVERSING EARLY STAGE KIDNEY FAILURE, curing TYPHOID FEVER and helping those with some types of CANCERS namely COLON CANCER, LIVER CANCER ABDOMINAL CANCER,HODGKIN'S LYMPHOMA and so on with empirical evidences. FDA Ghana approved medicines.

Our products are in the market, we have use cases and we have testimonials of healing.

BUSINESS PIPELINE

Franchises to Pharmaceutical companies for herbal medicine licenses with annual renewals
Franchises for the clinics for online and Face to Face
Branch into Gel, Paste and Ointment form product lines
Energy Drinks
Selling raw materials to other manufacturers and wholesalers
Collaborative research grants from governments and universities, idea is to generate patents for the formulas from the phytochemicals
International importing and exporting for the herbal medicine
Collaborate with other online Herbal medicine outlets

BUSINESS MODEL

We act as a Manufacturer selling to Wholesaler and Resell markets

B2B

Clinics

Hospitals

Pharmacies

Herbal outlets

B2C

Our website

Resellers ecommerce stores

B2G

Government lead programs

University research and grants

THE ASK

Daprof PowerTouch and Daprof Herbal Care requires $750,000 USD for 25% of the business to support a global expansion plans and retain our intellectual property. The investment is for 2 businesses, the ask enables funding for development of equipment and branding of our global project, production of goods in key markets and technology in digital health.

$750,000

Minimum Investment

Basic terms

Valuation $3 million

25% ownership (Equity)
Dividends
No voting rights

ROADMAP AND GO TO MARKET

Phase 1 (Q2 2023)

25% Seed Capital

Acquire market authorizations and licenses

Start Installation of equipment and training

Build online health clinic portal

Phase 2 (Q3 2024)

Rebranding

Kick off Marketing campaigns

Production starts

Build pipelines for sales (B2B, B2C and B2G markets)

Phase 3 (Q4 2024)

Continue advertising, Marketing and press releases

Continue Pipeline for Wholesalers and Resellers

COSTING

All the machines

Ghc 1,712,783.8065

USD 138,360

Installation, maintenance, and training

Ghc 160000

USD12,892.5

Freight, clearing duties

Ghc 500,000

USD 40,378.12

Business Development

Ghc 739,543.20

USD $60,000

Marketing and rebranding

Ghc 1,479,086.12

USD 120,000

Technology

Ghc 616,286.00

USD $50,000

Herbal plantation

Ghc 1050,000

USD 84,677.46

Labour remuneration for 10 staffs

Ghc 210000

USD 16935

Supporting working capital

Ghc 369,771.60

USD 30,000

Permit, market authorization, and international certification for all 20 FDA Ghana approved medicines in South Africa, Europe, and American markets

Ghc 2,000,000

USD 210,172,.25

SALES FORECASTS

Our sales are forecasted to increase rapidly, with an annual growth rate of approximately 70% to 100% from the 1st year to the 5th year.

Total sales

Year 1

Ghc2,654,545

USD272,342.03

Year 2

Ghc 4,495,455

USD 461,209.49

Year 3

Ghc 5,596,364

USD 574,156.83

Year 4

Ghc 8,990,910

USD 922,418.98

Year 5

Ghc 17,981,820

USD 1,844,837.95

Total direct cost

Year 1

Ghc 56,908.64

USD 5,838.52

Year 2

Ghc 71,161.73

USD 7,300.81

Year 3

Ghc 156,576.55

USD 16,063.91

Year 4

Ghc 355,805

USD 36,503.68

Year 5

Ghc 711,610

USD 73,007.36

DISTRIBUTION OF FUNDS

35% on Product Development

10% on Business development costs. People and systems

30% on Business Administration

5% on Tech Operations Costs

20% on the Go to Market, Marketing and Advertising

Term sheet and Agreement

Equipment - Installation, maintenance and training, Herbal plantation and Labor $280,000

GTM - Marketing and rebranding $120,000

BDM - $60,000

Technology - $50,000

Administration - Market authorization and international certification for all 20 FDA Ghana approved medicines in South Africa, Europe, and American markets $210,000

Cashflow - Supporting working capital $30,000 USD $750,000

AVY Project